Abstract
The effectiveness of a hybrid hydrogel platinum detachable coil (HydroCoil; MicroVention Inc., Tustin, CA) for endovascular aneurysm treatment has been proven in a recently published RCT. Due to technical restrictions (coil stiffness, time restriction for placement), the HydroSoft coil as well as a corresponding 3D framing coil, the HydroFrame coil (MicroVention Inc., Tustin, CA), a class of new softer coils containing less hydrogel and swelling more slowly than the HydroCoil, have been developed and brought to clinical practice. The present study aims to compare the effectiveness of endovascular aneurysm treatment with coil embolization between patients allocated HydroSoft/HydroFrame versus bare platinum coiling. GREAT is a randomized, controlled, multicentre trial in patients bearing cerebral aneurysms to be treated by coil embolization. Eligible patients were randomized to either coil embolization with HydroSoft/HydroFrame coils (>50 % of administered coil length), or bare platinum coils. Inclusion criteria were as follows: age 18–75, ruptured aneurysm (WFNS 1–3) and unruptured aneurysm with a diameter between 4 and 12 mm. Anatomy such that endovascular coil occlusion deemed possible and willingness of the neurointerventionalist to use either HydroSoft/HydroFrame or bare platinum coils. Exclusion criteria were as follows: aneurysms previously treated by coiling or clipping. Primary endpoint is a composite of major aneurysm recurrence on follow-up angiography and poor clinical outcome (modified Rankin scale 3 or higher), both assessed at 18 months post treatment. Risk differences for poor outcomes will be estimated in a modified intention-to-treat analysis stratified by rupture status (DRKS-ID: DRKS00003132).
Similar content being viewed by others
References
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International subarachnoid aneurysm trial (ISAT) collaborative group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360(9342):1267–1274
Taschner CA, Leclerc X, Gauvrit JY, Kerkeni A, El-Mahdy M, Lejeune JP, Pruvo JP (2007) Safety of endovascular treatment of intracranial aneurysms with a new, complex shaped Guglielmi detachable coil. Neuroradiology 49(9):761–766
White PM, Lewis SC, Gholkar A, Sellar RJ, Nahser H, Cognard C, Forrester L, Wardlaw JM, HELPS trial collaborators (2011) Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial. Lancet 377(9778):1655–1662
Tsumoto T, Niimi Y, Berenstein A (2009) Evaluation of the new HydroSoft coil in a canine model of bifurcation aneurysm. Laboratory investigation. J Neurosurg 111(1):11–16
Killer M, Kallmes D, Jones R, Ding Y, Vestal M, Hauser T, Virmani R, Cruise G (2010) Long-term angiographic and histological results of a new hydrogel-containing filling coil in experimental rabbit aneurysms. Minim Invasive Neurosurg 53(3):97–105
Guo XB, Fan YM, Zhang JN (2011) HydroSoft coil versus HydroCoil for endovascular aneurysm occlusion study: a single center experience. Eur J Radiol 79(2):e42–e46
Waldau B, Turk AS 3rd, Yashar P, Khaldi A, Turner RD 4th, Chaudry MI, Siddiqui AH, Levy EI, Hoh BL, Mocco J (2012) Perioperative safety of HydroSoft coils. J Neurointerv Surg 4(5):375–378
Park JH, Kang HS, Han MH, Jeon P, Yoo DS, Lee TH, Korean HydroSoft Registry Investigators (2011) Embolization of intracranial aneurysms with HydroSoft coils: results of the Korean multicenter study. AJNR Am J Neuroradiol 32(9):1756–1761
Lee JY, Seo JH, Lee SJ, Son YJ, Cho YD, Kang HS, Han MH (2014) Mid-term outcome of intracranial aneurysms treated with HydroSoft coils compared to historical controls treated with bare platinum coils: a single-center experience. Acta Neurochir (Wien) 156(9):1687–1694
Roy D, Milot G, Raymond J (2001) Endovascular treatment of unruptured aneurysms. Stroke 32(9):1998–2004
Raymond J, Guilbert F, Weill A, Georganos SA, Juravsky L, Lambert A, Lamoureux J, Chagnon M, Roy D (2003) Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 34(6):1398–1403
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607
White PM, Raymond J (2009) Endovascular coiling of cerebral aneurysms using "bioactive" or coated-coil technologies: a systematic review of the literature. AJNR Am J Neuroradiol 30(2):219–226
Molyneux AJ, Clarke A, Sneade M, Mehta Z, Coley S, Roy D, Kallmes DF, Fox AJ (2012) Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke 43(10):2544–2550
McDougall CG, Johnston SC, Gholkar A, Barnwell SL, Vazquez Suarez JC, Massó Romero J, Chaloupka JC, Bonafe A, Wakhloo AK, Tampieri D, Dowd CF, Fox AJ, Imm SJ, Carroll K, Turk AS, MAPS Investigators (2014) Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol 35(5):935–942
Raymond J, Klink R, Chagnon M, Barnwell SL, Evans AJ, Mocco J, Hoh BL, Turk AS, Turner RD, Desal H, Fiorella D, Bracard S, Weill A, Guilbert F, Roy D (2014) PRET Collaborative Group Patients prone to recurrence after endovascular treatment: periprocedural results of the PRET randomized trial on large and recurrent aneurysms. AJNR Am J Neuroradiol 35(9):1667–1676
Acknowledgments
The study was funded by MicroVention Inc., the manufacturers of the HydroSoft/Hydroframe coils. MicroVention Inc. also supplied the electronic case report form for data entry. We also thank Core Lab: Hubert Desal, Jens Fiehler, the Trial Steering Committee: Christian Taschner (Lead Investigator), Alain Bonafé (Co-ordinator, French Centres), Martin Schumacher, Matthias Reinhard, Vera van Velthoven and the Data Monitoring and Safety Committee: Daniel Rüfenacht (Chair), Werner Hacke, Meinhard Kieser (Statistician).
Ethical standards and patient consent
We declare that all human and animal studies have been approved by the leading Ethics Committee (Faculty of Medicine, Freiburg University, 077/09) and the local Ethics Committees and was authorized by the competent French and German authorities. The study is registered in the German Clinical Trials Register (DRKS-ID: DRKS00003132) and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. We declare that all patients gave informed consent according to the requirements of the study protocol approved by the Ethics Committees in France and Germany.
Conflict of interest
CAT has consulted for MicroVention Inc., Stryker Neurovascular and Acandis GmbH.
Participating centres and investigators
France
Department of Neuroradiology, CHU Besançon, Besançon; Alessandra Biondi
Department of Neuroradiology, CHU Bordeaux, Bordeaux; Xavier Barreau, Jérôme Berge
Department of Neuroradiology, CHU Caen, Caen; Patrick Courthéoux, C Barbier
Department of Neuroradiologie, Hôpital Gabriel-Montpied, CHU Clermont-Ferrand, Clermont-Ferrand; Betty Jean, Jean Gabrillargues, Emanuel Chabert, A Fischer
Department of Neuroradiology, CHU Dijon, Dijon; Frédéric Ricolfi
Department of Neuroradiology, CHU Limoges, Limoges, Charbel Mounayer
Department of Neuroradiology, Hôpital La Timone, CHU Marseille, Marseille; Hervé Brunel
Department of Neuroradiology, CHU Montpellier, Montpellier; Alain Bonafé, Vincent Costalat, Paolo Machi
Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris; Raphael Blanc, Michel Piotin, B Bartolini
Department of Neuroradiology, Hôpital Henri-Mondor, AP-HP, Paris; Sophie Gallas
Department of Neuroradiology, Hôpital Salpétrière, AP-HP, Paris; Nader Sourour
Department of Neuroradiology, CHU Reims, Reims; Laurent Pierot, Kryzsztof Kadziolka
Department of Neuroradiology, CHU Rennes, Rennes; Jean-Yves Gauvrit
Department of Neuroradiology, CHU Rouen, Rouen; Eléonore Tollard
Department of Neuroradiology, CHU Tours, Tours; Denis Herbreteau, C Papgiannaki, Richard Bibi
Germany
Department of Diagnostic and Interventional Radiology and Neuroradiology, Augsburg Hospital, Augsburg; Ansgar Berlis
Department of Intracranial Endovascular Therapy, Alfried-Krupp Krankenhaus Hospital, Essen, Germany; René Chapot, Paul Stracke
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen; Marc Schlamann, Sophia Göricke, Claudia Möller-Hartmann, Isabell Wanke
Institute of Neuroradiology, University Hospital Frankfurt, Frankfurt am Main; Joachim Berkefeld, Richard du Mesnil de Rochemont
Department of Neuroradiology, Medical Centre - University of Freiburg, Freiburg; Christian Taschner, Samer El Shikh, Stephan Meckel, Horst Urbach
Department of Neuroradiology, University Hospital Giessen, Giessen; Elke Gizewski
Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim; Christoph Groden
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taschner, C., Chapot, R., Costalat, V. et al. GREAT—a randomized aneurysm trial. Design of a randomized controlled multicenter study comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment. Neuroradiology 57, 599–604 (2015). https://doi.org/10.1007/s00234-015-1501-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-015-1501-0